MEDICAMEQ / NSE / Biotechnology & Drugs
Medicamen Biotech
1Y Price Trend
Key Information
Recommendations
Target High454
Target Low216
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk48
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Medicamen Biotech Ltd is Rated Strong Sell Markets Mojo
Medicamen Biotech Ltd Reports Strong Quarterly Turnaround Amid Long-Term Challenges Markets Mojo
Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges Markets Mojo
Medicamen Biotech Ltd is Rated Sell Markets Mojo
Medicamen Biotech Q4 FY26: Strong Quarter Masks Deeper Structural Concerns Markets Mojo
Medicamen Biotech FY26 net profit rises to ₹979.64 lakh scanx.trade
Medicamen Biotech Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 marketscreener.com
Medicamen Bio Standalone March 2026 Net Sales at Rs 54.68 crore, up 110.35% Y-o-Y Moneycontrol.com
Stock FAQs
What is the symbol and ISIN of Medicamen Biotech?
Medicamen Biotech has the symbol MEDICAMEQ and ISIN - INE646B01010.
What is the current price of Medicamen Biotech?
Medicamen Biotech is currently trading at INR 250.00.
What are the year high and year low of Medicamen Biotech?
Medicamen Biotech has a year high of INR 454.00 and a year low of INR 216.00.
What is the market capitalization of Medicamen Biotech?
Medicamen Biotech has a market capitalization of INR 340.57 crore.
What is the P/E ratio of Medicamen Biotech?
Medicamen Biotech has a P/E ratio of 28.75.
What is the dividend yield of Medicamen Biotech?
Medicamen Biotech has a dividend yield of 0.41%.
How is the financial performance of Medicamen Biotech based on revenue, net income, and EPS?
Medicamen Biotech has revenue of INR 1,977.70 crore, net income of INR 96.46 crore, and EPS of INR 7.77.
What is the book value of Medicamen Biotech?
Medicamen Biotech has a book value of INR 202.74.
What is the debt-to-equity ratio of Medicamen Biotech?
Medicamen Biotech has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Medicamen Biotech?
Medicamen Biotech has a price-to-book ratio of 1.23 and a price-to-sales ratio of 0.17.
© SharekeyX | Rusaka Technologies 2024-2026